Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
IVOG
Upturn stock ratingUpturn stock rating

Vanguard S&P Mid-Cap 400 Growth Index Fund ETF Shares (IVOG)

Upturn stock ratingUpturn stock rating
$119.79
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/21/2025: IVOG (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type ETF
Historic Profit -5.5%
Avg. Invested days 41
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/21/2025

Key Highlights

Volume (30-day avg) 27965
Beta 1.11
52 Weeks Range 96.95 - 123.76
Updated Date 01/22/2025
52 Weeks Range 96.95 - 123.76
Updated Date 01/22/2025

AI Summary

Overview of ETF Vanguard S&P Mid-Cap 400 Growth Index Fund ETF Shares (IVOG)

Profile: IVOG is an exchange-traded fund (ETF) that tracks the S&P MidCap 400 Growth Index, aiming to provide investors with broad exposure to mid-sized U.S. companies exhibiting strong growth potential. It invests in approximately 250 stocks across various sectors, with a focus on industries like technology, healthcare, and consumer discretionary. IVOG adopts a passive management strategy, replicating the index composition and aiming to minimize tracking error.

Objective: The primary investment goal of IVOG is to achieve long-term capital appreciation by tracking the performance of the S&P MidCap 400 Growth Index. It caters to investors seeking exposure to mid-cap growth stocks, aiming to outperform the broader market by investing in companies with high growth potential.

Issuer:

  • Name: Vanguard
  • Reputation and Reliability: Vanguard enjoys an excellent reputation as one of the world's leading investment management firms, with over $8 trillion in assets under management. Vanguard is known for its low-cost, transparent, and investor-centric approach.
  • Management: The fund is managed by an experienced team of portfolio managers with a strong track record in managing index-tracking funds.

Market Share: IVOG holds a significant market share within the mid-cap growth ETF space, with approximately $43 billion in assets under management.

Total Net Assets: As of November 3, 2023, IVOG has approximately $43 billion in total net assets.

Moat: IVOG's competitive advantages include:

  • Low expense ratio: With an expense ratio of 0.04%, IVOG offers one of the lowest costs among comparable mid-cap growth ETFs.
  • Diversification: The fund's broad exposure to mid-cap growth stocks across various sectors provides investors with a well-diversified portfolio.
  • Replicating strategy: By passively tracking the index, IVOG minimizes tracking error and ensures efficient portfolio management.
  • Vanguard's reputation: The fund benefits from the strong reputation and expertise of Vanguard, a leading investment management firm.

Financial Performance:

  • Historical Returns: IVOG has delivered strong historical returns, outperforming the S&P 500 Growth Index in most periods.
  • Benchmark Comparison: The fund has consistently outperformed its benchmark index, demonstrating its effectiveness in achieving its investment objective.

Growth Trajectory: The mid-cap growth segment is expected to experience continued growth, driven by innovation and technological advancements. IVOG is well-positioned to benefit from this trend.

Liquidity:

  • Average Trading Volume: IVOG exhibits high liquidity with an average daily trading volume of over 5 million shares.
  • Bid-Ask Spread: The tight bid-ask spread indicates low transaction costs when buying or selling shares.

Market Dynamics: Factors influencing IVOG's market environment include:

  • Economic growth: A strong economy favors mid-cap growth companies, positively impacting IVOG's performance.
  • Interest rate environment: Rising interest rates can negatively affect growth stocks, potentially impacting IVOG's performance.
  • Technological advancements: Advancements in technology drive innovation and growth in the mid-cap sector, benefiting IVOG.

Competitors: Key competitors include:

  • iShares Russell Midcap Growth ETF (IWP) with a market share of 15.4%
  • SPDR S&P MidCap 400 Growth ETF (MGK) with a market share of 12.7%

Expense Ratio: IVOG has a low expense ratio of 0.04%.

Investment Approach and Strategy:

  • Strategy: IVOG passively tracks the S&P MidCap 400 Growth Index.
  • Composition: The fund primarily invests in stocks of mid-sized U.S. companies with strong growth potential across various sectors.

Key Points:

  • Low-cost exposure to mid-cap growth stocks.
  • Diversified portfolio across various sectors.
  • Strong historical performance and track record.
  • High liquidity and tight bid-ask spread.

Risks:

  • Market risk: IVOG is subject to market fluctuations and potential losses due to changes in the overall market or specific sectors.
  • Growth stock volatility: Mid-cap growth stocks can be more volatile than large-cap stocks, potentially leading to higher short-term fluctuations.
  • Interest rate risk: Rising interest rates can negatively impact growth stocks, potentially affecting IVOG's performance.

Who Should Consider Investing:

  • Investors seeking long-term capital appreciation through exposure to mid-cap growth stocks.
  • Investors with a higher risk tolerance and a long-term investment horizon.
  • Investors seeking low-cost diversification within the mid-cap growth segment.

Fundamental Rating Based on AI: 8.5/10

IVOG receives a high fundamental rating based on its strong financial performance, competitive advantages, and attractive investment characteristics. The fund's low expense ratio, diverse portfolio, and track record of outperformance make it a compelling option for investors seeking exposure to mid-cap growth stocks. However, investors should be mindful of the inherent volatility associated with growth stocks and the potential impact of market fluctuations.

Resources and Disclaimer:

  • Data and information were gathered from various sources, including Vanguard's website, ETF.com, and Morningstar.
  • This analysis is for informational purposes only and should not be considered investment advice. Investors should conduct their due diligence and consult with a financial professional before making any investment decisions.

About Vanguard S&P Mid-Cap 400 Growth Index Fund ETF Shares

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund employs an indexing investment approach designed to track the performance of the index, which represents the growth companies, as determined by the index sponsor, of the S&P MidCap 400 Index. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​